Page last updated: 2024-09-04

isovitexin and Carcinoma, Non-Small Cell Lung

isovitexin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, RL; He, JQ; Huang, P; Sun, CH; Wang, Z; Yu, CH; Yu, WY; Zhang, HH	1

Other Studies

1 other study(ies) available for isovitexin and Carcinoma, Non-Small Cell Lung

Article	Year
Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice. International immunopharmacology, 2021, Volume: 94 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apigenin; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cytokines; Down-Regulation; Drug Synergism; Glucose; Humans; Killer Cells, Natural; Lactic Acid; Lung Neoplasms; Male; Membrane Proteins; Mice, Nude; T-Lymphocytes, Cytotoxic; Thyroid Hormone-Binding Proteins; Thyroid Hormones	2021

Article

Year

Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice.

International immunopharmacology, 2021, Volume: 94

Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apigenin; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cytokines; Down-Regulation; Drug Synergism; Glucose; Humans; Killer Cells, Natural; Lactic Acid; Lung Neoplasms; Male; Membrane Proteins; Mice, Nude; T-Lymphocytes, Cytotoxic; Thyroid Hormone-Binding Proteins; Thyroid Hormones

2021